玮俊生物科技(00660)发盈警 预期年度净亏损不超过1300万港元 同比显著减少

智通财经
Sep 26

智通财经APP讯,玮俊生物科技(00660)发布公告,集团预期于截至2025年6月30日止年度取得的净亏损不超过1300万港元,亏损相比截至2024年6月30日止年度的净亏损约6570万港元大幅减少。亏损大幅减少的主要原因为报告年度内非金融资产减值亏损减少。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10